Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-02Clinical Trial Update: Safety and Efficacy of CG0070 Oncolytic Virus Regimen in Patients With High Grade Non-Muscle Invasive Bladder Cancer [Phase 2]
Phase 2 trial of CG0070 for high-grade non-muscle invasive bladder cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-03-17Clinical Trial Update: A Study of NDV-01 as an Intravesical Administration to Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC), Refractory to First-line Therapy [Phase 3]
Relmada Therapeutics has withdrawn its Phase 3 trial of NDV-01 administered intravesically for BCG-unresponsive non-muscle invasive bladder …
-
CLINICAL_TRIALS withdrawal · 2025-10-21Clinical Trial Update: Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial [Phase 2]
The NERA trial, a Phase 2 study of erdafitinib with or without atezolizumab in localized bladder cancer patients ineligible for cisplatin ch…
-
CLINICAL_TRIALS withdrawal · 2025-09-04Clinical Trial Update: PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9 [Phase 1]
Phase 1 trial evaluating PET imaging agents 64Cu-Tz-SarAr and hu5B1-TCO in pancreatic, colorectal, and bladder cancers (including cancers wi…
-
CLINICAL_TRIALS withdrawal · 2025-04-04Clinical Trial Update: A Study Comparing a Disposable Flexible Cystoscope With Reusable Scopes in Adult Patients. [NA]
The trial comparing a disposable flexible cystoscope with reusable scopes in adult patients has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-11-22Clinical Trial Update: A Trial to Evaluate Efficacy of Reinduction With Nadofaragene Firadenovec in Subjects With CIS ± High-grade Ta/T1 and no Complete Response to First Nadofaragene Firadenovec Dose. [Phase 4]
A Phase 4 trial evaluating reinduction with Nadofaragene firadenovec in bladder cancer patients with CIS ± high-grade Ta/T1 and no complete …
-
CLINICAL_TRIALS withdrawal · 2024-10-15Clinical Trial Update: Comparative Microbial Analysis of Cystitis in Non-muscle-invasive Bladder Cancer Patients Using Vikor Scientific Urine-ID Testing Menu (IDTM) and Standard Laboratory Culture
This clinical trial update indicates that NCT04583553, a study comparing Urine-ID Testing Menu (IDTM) with standard culture for cystitis in …
-
CLINICAL_TRIALS withdrawal · 2024-10-08Clinical Trial Update: InveStigAting Bladder fiELd-cycLing imAging [NA]
A University of Aberdeen-sponsored clinical trial investigating bladder cancer imaging has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: TAS-116 Plus Palbociclib in Breast and Rb-null Cancer [Phase 1]
A Phase 1 trial investigating TAS-116 in combination with palbociclib for advanced breast cancer and RB-deficient solid tumors has been with…
-
CLINICAL_TRIALS withdrawal · 2024-04-24Clinical Trial Update: A Novel Application of 2% Lidocaine Injection for Male Rigid cycstoscopy-a Patient-blinded Randomised Trial [Phase 3]
A Phase 3 randomized trial evaluating 2% lidocaine injection for male rigid cystoscopy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-06-12Clinical Trial Update: Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder Cancer [Phase 3]
A Phase 3 trial investigating rapamycin for secondary prevention in patients with resected non-muscle invasive bladder cancer has been withd…
-
CLINICAL_TRIALS withdrawal · 2018-05-07Clinical Trial Update: RITE-EUROPE (Radiofrequency-Induced Thermochemotherapy Effect-EUROPE) [Phase 3]
A Phase 3 clinical trial called RITE-EUROPE examining bladder cancer has been withdrawn. The study status is listed as withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-02-26Clinical Trial Update: Intervention Protocol for Automated Point-of-Care Surveillance of Outpatient Delays in Cancer Diagnosis [NA]
Clinical trial NCT01710293, sponsored by the VA Office of Research and Development, has been withdrawn. The study evaluated an intervention …
-
CLINICAL_TRIALS withdrawal · 2017-10-19Clinical Trial Update: Radiation Therapy and Durvalumab, With or Without Tremelimumab, in Patients With Bladder Cancer [Phase 2]
A Phase 2 trial evaluating radiation therapy with durvalumab, with or without tremelimumab, for bladder cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-11-09Clinical Trial Update: Urinary Diversion During Robotic Assisted Radical Cystectomy in Patients With Bladder Cancer [NA]
A clinical trial evaluating urinary diversion during robotic-assisted radical cystectomy for bladder cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-04-24Clinical Trial Update: Recurrence of Bladder Cancer After Transurethral Resection With Hexvix [Phase 4]
A Phase 4 trial evaluating recurrence of bladder cancer after transurethral resection with Hexvix has been withdrawn; no further recruitment…
-
CLINICAL_TRIALS withdrawal · 2014-10-07Clinical Trial Update: Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer [Phase 3]
A Phase 3 trial comparing hyperthermia with mitomycin C to Bacillus Calmette-Guérin (BCG) immunotherapy for superficial bladder cancer was t…
-
CLINICAL_TRIALS withdrawal · 2014-10-02Clinical Trial Update: MRI and Bladder Cancer Chemotherapy
A clinical trial investigating MRI-guided techniques with chemotherapy for invasive bladder cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-07-29Clinical Trial Update: Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer [NA]
A clinical trial evaluating imaging during surgery to diagnose prostate, bladder, or kidney cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-01-29Clinical Trial Update: Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer [Phase 2]
This Phase 2 clinical trial evaluating gemcitabine plus cisplatin or a high-dose methotrexate/vinblastine/doxorubicin/cisplatin regimen for …
-
CLINICAL_TRIALS withdrawal · 2013-12-19Clinical Trial Update: Gemcitabine in Treating Patients With Recurrent or Refractory Bladder Cancer [Phase 1]
A Phase 1 study of Gemzar (gemcitabine) in patients with recurrent or refractory bladder cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-08-14Clinical Trial Update: Comparison of Standard of Care or Treatment on Protocol [NA]
A terminated clinical trial (NCT01010334) comparing standard of care versus a protocol treatment. The study covers several cancers, includin…
-
CLINICAL_TRIALS withdrawal · 2013-07-15Clinical Trial Update: Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder [NA]
A clinical trial evaluating the combination of celecoxib and rosiglitazone for bladder cancer patients undergoing surveillance for early-sta…
-
CLINICAL_TRIALS withdrawal · 2013-01-17Clinical Trial Update: Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer [Phase 2]
A Phase 2 trial of lapatinib plus weekly paclitaxel for advanced urothelial cancer has been withdrawn.